We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOCU
176
PUT
DocuSign
DOCU
$11.3B
$260M 0.07%
1,168,700
+205,000
+21% +$46M
ZM icon
177
Zoom
ZM
$31.1B
$257M 0.07%
761,782
+713,980
+1,494% +$318M
HD icon
178
Home Depot
HD
$353B
$255M 0.07%
958,702
+594,396
+163% +$163M
UPS icon
179
PUT
United Parcel Service
UPS
$88.8B
$250M 0.07%
1,486,500
-185,500
-11% -$31.3M
ZBH icon
180
Zimmer Biomet
ZBH
$18.5B
$249M 0.06%
1,662,241
+867,560
+109% +$123M
MRNA icon
181
PUT
Moderna
MRNA
$24.2B
$248M 0.06%
2,372,100
+731,200
+45% +$74M
HSY icon
182
Hershey
HSY
$36.6B
$247M 0.06%
1,623,480
+1,118,025
+221% +$165M
T icon
183
PUT
AT&T
T
$168B
$245M 0.06%
11,275,316
+683,316
+6% +$14.7M
PANW icon
184
CALL
Palo Alto Networks
PANW
$313B
$245M 0.06%
4,129,200
+1,564,800
+61% +$73.1M
NXPI icon
185
NXP Semiconductors
NXPI
$59.6B
$244M 0.06%
1,535,285
+1,377,643
+874% +$203M
REGN icon
186
CALL
Regeneron Pharmaceuticals
REGN
$82.1B
$243M 0.06%
502,600
+51,600
+11% +$27.9M
BIIB icon
187
PUT
Biogen
BIIB
$30.1B
$242M 0.06%
988,800
+316,200
+47% +$81.6M
ENPH icon
188
PUT
Enphase Energy
ENPH
$5.59B
$242M 0.06%
1,379,100
+950,900
+222% +$121M
PTON icon
189
CALL
Peloton Interactive
PTON
$2.46B
$242M 0.06%
1,594,100
-651,900
-29% -$79.4M
EMR icon
190
Emerson Electric
EMR
$91.7B
$242M 0.06%
3,006,191
+2,954,165
+5,678% +$220M
ORCL icon
191
CALL
Oracle
ORCL
$419B
$241M 0.06%
3,723,000
+1,373,100
+58% +$81.7M
ON icon
192
ON Semiconductor
ON
$31.6B
$241M 0.06%
7,357,885
+3,523,347
+92% +$98.3M
UNP icon
193
Union Pacific
UNP
$174B
$241M 0.06%
1,155,989
+526,676
+84% +$105M
LOW icon
194
CALL
Lowe's Companies
LOW
$124B
$240M 0.06%
1,496,100
+511,900
+52% +$83.2M
PG icon
195
CALL
Procter & Gamble
PG
$338B
$240M 0.06%
1,722,000
-118,900
-6% -$16.6M
TDOC icon
196
PUT
Teladoc Health
TDOC
$1.24B
$239M 0.06%
1,197,553
+668,753
+126% +$136M
TWTR
197
DELISTED
Twitter, Inc.
TWTR
$239M 0.06%
4,415,198
+3,779,272
+594% +$180M
Z icon
198
Zillow
Z
$7.68B
$237M 0.06%
1,828,987
+416,497
+29% +$46.1M
CAT icon
199
Caterpillar
CAT
$388B
$237M 0.06%
1,303,376
+1,100,912
+544% +$187M
XLNX
200
DELISTED
Xilinx Inc
XLNX
$237M 0.06%
1,670,093
+1,235,170
+284% +$161M

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.